Robotic‐assisted versus conventional laparoscopic approach in patients with large rectal endometriotic nodule: the evaluation of safety and complications
Colorectal Disease · 2023
DOI: 10.1111/codi.16785 ↗At a glance
Journal article in Colorectal Disease, 2023. Written by Alexander Volodarsky-Perel and 5 co-authors. Institution: Franco-European Multidisciplinary Endometriosis Institute (IFEMEndo), Clinique Tivoli-Ducos, Bordeaux, France. Major MEDLINE topics: Digestive System Surgical Procedures, Endometriosis, Robotic Surgical Procedures, Rectal Diseases. Cited 11 times so far (Crossref); 31 references.
Abstract (original language)
Aim
The aim was to compare postoperative complications in patients undergoing the excision of a rectal endometriotic nodule over 3 cm by a robotic‐assisted versus a conventional laparoscopic approach.
Methods
We conducted a retrospective cohort study evaluating prospectively collected data. The main interventions included rectal shaving, disc excision or colorectal resection. All the surgeries were performed in one endometriosis reference institute. To evaluate factors significantly associated with the risk of anastomosis leakage or fistula and bladder atony, we conducted a multivariate logistic regression model.
Results
A total of 548 patients with rectal endometriotic nodule over 3 cm in diameter (#ENZIAN C3) were included in the final analysis. The demography and clinical characteristics of women managed by the robotic‐assisted ( n = 97) approach were similar to those of patients who underwent conventional laparoscopy ( n = 451). The multivariate logistic regression demonstrated that the surgical approach (robotic‐assisted vs. laparoscopic) was not associated with the rate of anastomosis leakage or fistula (adjusted odds ratio [aOR] 1.2, 95% confidence interval [CI] 0.3–4.0) and bladder dysfunction (aOR 0.5, 95% CI 0.1–1.8). A rectal nodule located lower than 6 cm from the anal verge was significantly associated with anastomosis leakage (aOR 4.1, 95% CI 1.4–10.8) and bladder atony (aOR 4.3, 95% CI 1.5–12.3). Anastomosis leakage was also associated with smoking (aOR 3.2, 95% CI 1.4–7.4), significant vaginal infiltration (aOR 2.7, 95% CI 1.2–6.7) and excision of nodules involving sacral roots (aOR 5.6, 95% CI 1.7–15.5).
Conclusion
The robotic‐assisted approach was not associated with increased risk of main postoperative complications compared to conventional laparoscopy for the treatment of large rectal endometriotic nodules.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Franco-European Multidisciplinary Endometriosis Institute (IFEMEndo), Clinique Tivoli-Ducos, Bordeaux, France.
- Sheba Medical Center at Tel HaShomer, Ramat Gan, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Bordeaux Colorectal Institute, Clinique Tivoli-Ducos, Bordeaux, France.
- Franco-European Multidisciplinary Endometriosis Institute Middle East Clinic, Burjeel Medical City, Abu Dhabi, United Arab Emirates.
ORCID profiles: Alexander Volodarsky-Perel, Horace Roman
Cite
APA
Volodarsky-Perel, A., Merlot, B., Denost, Q., Dennis, T., Chanavaz-Lacheray, I., & Roman, H. (2023). Robotic‐assisted versus conventional laparoscopic approach in patients with large rectal endometriotic nodule: the evaluation of safety and complications. Colorectal Disease. https://doi.org/10.1111/codi.16785
Vancouver
Volodarsky-Perel A, Merlot B, Denost Q, Dennis T, Chanavaz-Lacheray I, Roman H. Robotic‐assisted versus conventional laparoscopic approach in patients with large rectal endometriotic nodule: the evaluation of safety and complications. Colorectal Disease. 2023. doi:10.1111/codi.16785
BibTeX
@article{VolodarskyPerel2023,
author = {Volodarsky-Perel, Alexander and Merlot, Benjamin and Denost, Quentin and Dennis, Thomas and Chanavaz-Lacheray, Isabella and Roman, Horace},
title = {Robotic‐assisted versus conventional laparoscopic approach in patients with large rectal endometriotic nodule: the evaluation of safety and complications},
journal = {Colorectal Disease},
year = {2023},
doi = {10.1111/codi.16785}
}
EUVIMED